Contact Information
4302 S Bernson Lane
Spokane, WA 99223
Rebecca Nelson
Area Businesses Specialist
406-799-1631
INVEGA HAFYERATM (paliperidone palmitate) is the only schizophrenia medication that can help continuously control your symptoms with just 2 doses a year after being adequately treated with INVEGA SUSTENNA® (paliperidone palmitate) for at least 4 months or INVEGA TRINZA® (paliperidone palmitate) for one 3-month cycle. INVEGA HAFYERATM has the same medication for schizophrenia as INVEGA SUSTENNA® (paliperidone palmitate) and INVEGA TRINZA® (paliperidone palmitate) but is given once every 6 months.
In making the transition to INVEGA HAFYERATM, you can feel confident that the schizophrenia medication you need is being gradually released into your system every day for 6 months to help control symptoms. And long-acting injections (LAIs) like INVEGA HAFYERATM can help delay another episode so you can focus more on what’s important to you: your hobbies, your goals, and your future.
In a pivotal long-term study, 90% of adult patients taking INVEGA SUSTENNA® did not experience a significant return of schizophrenia symptoms vs 66% of those not treated.
In a separate pivotal long-term study, 93% of adult patients taking INVEGA TRINZA® did not experience a significant return of schizophrenia symptoms vs 77% of those not treated.
A long-term, global clinical study was conducted to show whether INVEGA HAFYERATM was as effective as INVEGA TRINZA® in symptom control with similar safety and side effects. In this study, 92.5% of patients treated with INVEGA HAFYERATM and 95% of patients treated with INVEGA TRINZA® did not experience an episode at 12 months.
The Janssen portfolio of LAIs has 3 treatment options with the same active ingredient, designed to be gradually released to help control schizophrenia symptoms and delay time to another relapse in adults.
The Montana Psychiatry Conference makes every attempt to provide accurate and timely content available for users. Neither MPC nor third-party content providers are responsible or liable for any such content, including advertising, products or other materials available through third party sites.
Copyright © 2024 The Montana Psychiatry Conference - All Rights Reserved.
Powered by GoDaddy